Keisuke Sugimoto

Dr. Keisuke Sugimoto

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Journal of Veterinary Science
Verified
Journal Article
Open access
KSKeisuke Sugimoto
Keisuke Sugimoto
NKNana Kawase
Nana Kawase
TATakuma Aoki
Takuma Aoki
YFYoko Fujii
Yoko Fujii
This study aimed to assess the effects of dehydration on echocardiographic indices in healthy cats: specifically, it aimed to assess the effects of volume depletion on diastolic function. Nine experimental cats were subjected to both a dehydration and placebo protocol separated by a 21-day washout period. Echocardiography was performed at baseline and on completion of each protocol. Results were compared between the two protocols. Volume depletion was induced by intravenous administration of furosemide. Volume depletion showed a significant association with increased interventricular septal and left ventricular free wall thickness at end-diastole, decreased left ventricular internal diameter at end-diastole, and left atrial diameter at end-systole. The peak early (E) and late (A) diastolic filling velocities, and the peak early diastolic velocities (E') were significantly decreased by dehydration. Volume depletion did not affect peak longitudinal strain rate during early diastole, E/A, or E/E'. Volume depletion significantly affected the echocardiographic diastolic indices and conventional echocardiographic parameters in healthy cats.

1 January 2020 in Journal of Veterinary Medical Science
Verified
Journal Article
Open access
PDF file
KSKeisuke Sugimoto
Keisuke Sugimoto
TATakuma Aoki
Takuma Aoki
YFYoko Fujii
Yoko Fujii
This study aimed to assess the effects of atenolol on left ventricular (LV) and left atrial (LA) function in healthy cats and investigate the relationship between atenolol administration and LA enlargement (LAE) in cats with hypertrophic cardiomyopathy (HCM). In study 1, nine experimental cats were used to assess the effects of atenolol in healthy subjects. Cats were administered one of three medication protocols for 7 days: atenolol 6.25 mg/cat twice daily, 12.5 mg/cat twice daily, or placebo (biofermin) 1 tab/cat twice daily. In study 2, cats with HCM were retrospectively recruited and divided into four groups according to atenolol administration [(control group (Cont) or atenolol administration group (Ate)] and the presence or absence of LAE as follows: Cont LAE (–) group (n=42), Cont LAE (+) group (n=20), Ate LAE (–) group (n=17), and Ate LAE (+) group (n=12). LV and LA functions were compared in both studies. LV and LA functions were decreased by atenolol administration in study 1. In study 2, the peak myocardial velocity during early diastole (E’) was significantly decreased in the Cont LAE (+), Ate LAE (–), and Ate LAE (+) groups compared to that in the Cont LAE (–) group, but there were no significant differences between LAE (+) groups. Multivariate logistic analysis revealed that atenolol administration was not associated with LAE. Diastolic dysfunction may be associated with LAE; however, atenolol administration did not affect LAE in cats with HCM.

8 June 2021 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
YMYohei Mochizuki
Yohei Mochizuki
SMShoma Mikawa
Shoma Mikawa
KKKenji Kutara
Kenji Kutara
KSKeisuke Sugimoto
Keisuke Sugimoto
HSHirosei Sakoya
Hirosei Sakoya
TATaketoshi Asanuma
Taketoshi Asanuma
A 1-year-old female Akita dog was referred for intermittent regurgitation. Computed tomographic angiography (CTA) showed an aberrant right subclavian artery (ARSA), resulting in constriction of the esophagus. After surgical ligation of the ARSA, CTA showed that the ARSA was not enhanced by contrast medium, and that sufficient collateral circulation of the right forelimb was supplied through the vertebral artery. Furthermore, the right and left vertebral arteries merged into the basilar artery at the level of the atlas, and no abnormal expansion of the ventral spinal artery was observed. Overall, we demonstrated the importance of post-surgical CTA for identification of surgical complications, including the formation of abnormal vessel alterations.

2 August 2022 in Veterinary Medicine and Science
Verified
Journal Article
Open access
TITakamasa Itoi
Takamasa Itoi
NANatsuki Akashi
Natsuki Akashi
YSYuki SHIMIZU
Yuki SHIMIZU
KSKeisuke Sugimoto
Keisuke Sugimoto
AHAkihisa Hata
Akihisa Hata
TKTeppei Kanda
Teppei Kanda
A 3‐year‐old neutered male golden retriever administered zonisamide for the treatment of seizures showed lethargy and had normal anion gap metabolic acidosis with hypokalaemia, hyperchloremia, and alkaline urine. The serum zonisamide concentration was close to the upper limit, which raised a suspicion of adverse effects of zonisamide. This is the first report showing that the fractional excretion of bicarbonate after compensation for the plasma bicarbonate concentration by a sodium bicarbonate infusion was approximately 5%, indicating distal renal tubular acidosis (RTA). The serum zonisamide concentration decreased, and adverse effects were abated by reducing the zonisamide dosage. Diagnostic therapy with bicarbonate served as a means of compensating for bicarbonate deficiency and contributed to the clinical diagnosis of the condition in zonisamide‐associated RTA in dogs.

11 April 2022 in Animals
Verified
Journal Article
Open access
PDF file
KSKeisuke Sugimoto
Keisuke Sugimoto
KSKazutoshi Sugita
Kazutoshi Sugita
KOKensuke Orito
Kensuke Orito
YFYoko Fujii
Yoko Fujii
The aims of this study were to investigate the effects of repeated and multiple-dose pimobendan on cardiac systolic function and the correlations between changes in cardiac systolic function and plasma concentrations of pimobendan and O-desmethylpimobendan (ODMP). Five clinically healthy cats were subjected to four different medication protocols for 14 days, with a washout period of at least 1 month between each protocol. The protocols were pimobendan 0.5 mg/kg q12h (high dosage [HD] group); pimobendan 0.25 mg/kg q12h (standard dosage [SD] group); pimobendan 0.125 mg/kg q12h (low dosage group); and Biofermin R, one tablet q12h (placebo group). Echocardiography and measurement of plasma concentrations of pimobendan and ODMP were performed prior to medication administration (baseline) and 20, 40, 60, 120, 240, 360, and 480 min after administration, and the correlation between the changes in cardiac systolic function and plasma concentration of pimobendan, ODMP, or the sum of both were examined. The cardiac systolic function increased in the HD and SD groups, and there were significant correlations between the lateral peak systolic myocardial velocity (S′) changes and plasma pimobendan, plasma ODMP, and the sum of both. Repeated doses of pimobendan in healthy cats increased cardiac systolic function, and there were significant correlations between cardiac function and plasma concentrations of pimobendan and ODMP. The results of this study highlight the effectiveness of a higher dose of pimobendan.

1 June 2021 in Journal of Veterinary Cardiology
Verified
Journal Article
Closed access
MKM. Kochi
M. Kochi
KSKeisuke Sugimoto
Keisuke Sugimoto
SKS. Kawamoto
S. Kawamoto
MIM. Inoue
M. Inoue
NMN. Machida
N. Machida